跳至主要内容
临床试验/NCT07454824
NCT07454824招募中不适用

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

Johns Hopkins University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年4月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Number of patients who open the patient portal message

研究概览

简要总结

The overarching goal of this study is to pilot an intervention in which older adults with mild cognitive impairment and dementia and the older adult's care partners are identified in primary care and provided with educational materials through the patient portal to engage the participant in deprescribing. The multicomponent intervention, e-Align, includes delivery of educational information through the patient portal, and a pharmacist-led intervention to align medications with patient and care partner goals and reduce use of central nervous system (CNS) potentially inappropriate medicines (PIM). This work will establish the preliminary data, methods, and partnerships to undertake a multisite embedded pragmatic clinical trial. The resulting triadic-based behavioral intervention will promote patient and care partner engagement, and foster care that aligns with patients' values, and promote improved health and well-being outcomes for people with cognitive impairment and the patient's care partners through deprescribing.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

盲法说明

Due to the nature of the intervention, participants cannot be masked.

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients: Age ≥65, with a diagnosis of MCI or dementia based on ICD-10 codes and ≥1 active CNS-PIM, who are active patient portal users.
  • Care partners:
  • Family or other companions >21 years who regularly help the patient with managing medications.

排除标准

  • As the trial will be based in primary care, individuals residing in long term care facilities or enrolled in hospice will be excluded.

研究组 & 干预措施

Patient Portal Deprescribing Intervention

Experimental

e-ALIGN will be piloted via the patient portal. The intervention will provide patients and care partners with an educational video on the risks of Central Nervous System-Potentially Inappropriate Medications (CNS-PIM) through the patient portal, MyChart. It will also offer the participant the opportunity to discuss deprescribing options with the patient's primary care physician (PCP) or to receive a referral to discuss deprescribing options with a clinical pharmacist who is embedded in the primary care practice.

Patients who meet with the pharmacist will have two visits (intervention and follow-up). Patients who do not meet with a pharmacist will have a routine visit with the patient's PCP. Each participant will be on study (intervention period and additional follow-up) for approximately 3 months.

干预措施: e-ALIGN Patient-Portal Deprescribing (Other)

结局指标

主要结局

Number of patients who open the patient portal message

时间窗: 1 month after sending message

The investigators will assess the number of patients and/or care partners who read the patient portal message sent by the study team, which invites the participant to meet with a clinical pharmacist for deprescribing.

Number of patients who watch the video

时间窗: 1 month after sending message

The investigators will assess the number of patients who click and watch the educational video about CNS-PIM and deprescribing.

Acceptability of educational video assessed by survey

时间窗: 1 month after sending message

The investigators will assess the acceptability of the educational video by administering a survey to participants. The survey will ask participants to rate various features of the video on a 5-point Likert scale, where a higher score indicates greater acceptability.

次要结局

  • Number of patients or care partners that discussed deprescribing with any clinicians after receiving the message(3 months after sending message)
  • Number of PCPs who send the referral(3 months after sending message)
  • Number of patients who schedule the pharmacist visit(3 months after sending message)
  • Number of patients who deprescribe ≥1 CNS-PIM after receiving the message(3 months after sending message (for patients who do NOT have a pharmacist visit))
  • Number of patients who start ≥1 CNS-PIM after receiving the message(3 months after sending message (for people who do NOT have a pharmacist visit))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

e-ALIGN: A Patient Portal-based Intervention to... | 临床试验